15th & 16th Semi-Annual Diagnostic Coverage and Reimbursement Conference

December 3-4, 2019 | Boston, MA
February 11-12, 2020 | San Diego, CA

15th & 16th Semi-Annual Diagnostic Coverage and Reimbursement Conference
December 3-4, 2019 | Boston, MA
February 11-12, 2020 | San Diego, CA

Download Agenda - BOS

Download Agenda - SD

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I would definitely return next year. The speakers were people in the industry who are challenging to get access to via phone and email. They were all willing to chat post-meeting and were easily accessible.”

National Director, Market Access
Adaptive Biotechnologies

“Best reimbursement conference I have been to, ever.”

Vice President, Commercial Operations
Trovagene

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

Striving to maximize profitability, reimbursement professionals within diagnostic manufacturers and laboratories must contend with decreasing payment rates due to PAMA as well as increasing requirements for prior authorization and uncertainty regarding PLA code effectiveness. The Q1’s Diagnostic Coverage & Reimbursement Conferences offer industry leaders practical insight into strategies to develop test-specific frameworks and meet the growing need for clinical utility and product performance evidence. Reimbursement professionals will benefit from peer-to-peer sharing of tactics to clearly define end-points in diagnostic clinical trial design, methods to position real-world evidence for maximum impact to payers, and important private payer and government policy updates effecting payment for diagnostics.

Core Topics to be Addressed:

  • Payer Perspectives on Diagnostic Evidence & Access
  • Maximizing Coverage through Laboratory Benefit Management
  • Evidence Targets: Generating & Leveraging Clinical Evidence
  • Defining Diagnostic Value Relative to Costs for Payer Networks
  • Impact of Increasing Demand for Prior Authorizations
  • Evolving Health Policy Impact on Test Coverage & Reimbursement

Program Highlights:

  • Robust Industry Participation & Support
  • Interactive Small-Group Discussions Throughout
  • Stakeholder Perspectives Including:
    • Payer Medical Directors
    • Payer Contracting Executives
    • Laboratory Benefit Managers

Core Topics to be Addressed:

  • Payer Perspectives on Diagnostic Evidence & Access
  • Maximizing Coverage through Laboratory Benefit Management
  • Evidence Targets: Generating & Leveraging Clinical Evidence
  • Defining Diagnostic Value Relative to Costs for Payer Networks
  • Impact of Increasing Demand for Prior Authorizations
  • Evolving Health Policy Impact on Test Coverage & Reimbursement

Download Agenda – Boston

Download Agenda – San Diego

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

Audience

75 Attendees

All attendees come directly from laboratories and diagnostic companies

Distinguished Presenters

21-23 Speakers

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This